FoxP3 scanning mutagenesis reveals functional variegation and mild mutations with atypical autoimmune phenotypes

Significance The transcription factor FoxP3 defines and controls regulatory T cells (Tregs), themselves essential components of immunoregulatory pathways. From a highly granular scanning mutagenesis, the results of our study point to very integrated functions of the protein’s domains, quite different from predictions of simple modular models. The phenotype of mutant mice carrying subtle mutations in Foxp3, which deviate from the acute lymphoproliferation and autoimmunity linked to Treg deficiency and become manifest only upon challenge, suggest that rare FOXP3 variants may contribute to a broader range of human diseases than previously recognized. FoxP3+ regulatory T cells (Tregs) are a central element of immunological tolerance. FoxP3 is the key determining transcription factor of the Treg lineage, interacting with numerous cofactors and transcriptional targets to determine the many facets of Treg function. Its absence leads to devastating lymphoproliferation and autoimmunity in scurfy mutant mice and immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) patients. To finely map transcriptionally active regions of the protein, with respect to disease-causing variation, we performed a systematic alanine-scan mutagenesis of FoxP3, assessing mutational impacts on DNA binding and transcriptional activation or repression. The mutations affected transcriptional activation and repression in a variegated manner involving multiple regions of the protein and varying between different transcriptional targets of FoxP3. There appeared to be different modalities for target genes related to classic immunosuppressive function vs. those related to atypical or tissue-Treg functions. Relevance to in vivo Treg biology was established by introducing some of the subtle Foxp3 mutations into the mouse germline by CRISPR-based genome editing. The resulting mice showed Treg populations in normal numbers and exhibited no overt autoimmune manifestations. However, Treg functional defects were revealed upon competition or by system stress, manifest as a strikingly heightened susceptibility to provoked colitis, and conversely by greater resistance to tumors. These observations suggest that some of the missense mutations that segregate in human populations, but do not induce IPEX manifestations, may have unappreciated consequences in other diseases.

[1]  C. Benoist,et al.  Different molecular complexes that mediate transcriptional induction and repression by FoxP3 , 2017, Nature Immunology.

[2]  Ryuichi Murakami,et al.  Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells , 2017, Immunity.

[3]  J. Kirkwood,et al.  Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity , 2017, Cell.

[4]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[5]  G. Plitas,et al.  Genetic and epigenetic variation in the lineage specification of regulatory T cells , 2015, eLife.

[6]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[7]  Michael J. T. Stubbington,et al.  The Regulatory T Cell Lineage Factor Foxp3 Regulates Gene Expression through Several Distinct Mechanisms Mostly Independent of Direct DNA Binding , 2015, PLoS genetics.

[8]  Lee E. Edsall,et al.  DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactions , 2015, Nucleic acids research.

[9]  H. Dyson,et al.  Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.

[10]  Chun Jimmie Ye,et al.  Intersection of population variation and autoimmunity genetics in human T cell activation , 2014, Science.

[11]  J. Stamatoyannopoulos,et al.  Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells , 2014, Nature Immunology.

[12]  Steven F. Ziegler,et al.  FOXP3 and scurfy: how it all began , 2014, Nature Reviews Immunology.

[13]  B. Stranger,et al.  Interindividual variation in human T regulatory cells , 2014, Proceedings of the National Academy of Sciences.

[14]  T. Chatila,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. , 2013, Current opinion in pediatrics.

[15]  Martha L. Bulyk,et al.  DNA-binding specificity changes in the evolution of forkhead transcription factors , 2013, Proceedings of the National Academy of Sciences.

[16]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[17]  D. Koller,et al.  Conservation and divergence in the transcriptional programs of the human and mouse immune systems , 2013, Proceedings of the National Academy of Sciences.

[18]  R. Morita,et al.  Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis , 2013, Nature Immunology.

[19]  R. Bacchetta,et al.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..

[20]  Xiaomin Song,et al.  Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. , 2012, Cell reports.

[21]  J. Ellwart,et al.  Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells , 2012, European journal of immunology.

[22]  S. Ziegler,et al.  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. , 2012, Immunity.

[23]  A. Rudensky,et al.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. , 2012, Immunity.

[24]  T. Torgerson,et al.  The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2012, Journal of Medical Genetics.

[25]  A. G. Betz,et al.  Comparative Genomics Reveals Key Gain-of-Function Events in Foxp3 during Regulatory T Cell Evolution , 2012, Front. Immun..

[26]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[27]  U. Beier,et al.  Two Lysines in the Forkhead Domain of Foxp3 Are Key to T Regulatory Cell Function , 2012, PloS one.

[28]  J. Stroud,et al.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. , 2011, Immunity.

[29]  Mark S. Sundrud,et al.  Domain Requirements and Sequence Specificity of DNA Binding for the Forkhead Transcription Factor FOXP3 , 2009, PloS one.

[30]  W. Hancock,et al.  Three Distinct Domains Contribute to Nuclear Transport of Murine Foxp3 , 2009, PloS one.

[31]  A. Rudensky,et al.  CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner , 2009, Science.

[32]  A. Keegan Faculty Opinions recommendation of Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. , 2009 .

[33]  W. Friedrich,et al.  Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. , 2008, The Journal of allergy and clinical immunology.

[34]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[35]  Christophe Benoist,et al.  Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.

[36]  T. Chatila,et al.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. , 2007, International immunology.

[37]  Yuan Shen,et al.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression , 2007, Proceedings of the National Academy of Sciences.

[38]  S. Ziegler,et al.  Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor1 , 2006, The Journal of Immunology.

[39]  Shimon Sakaguchi,et al.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. , 2006, International immunology.

[40]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[41]  S. Ziegler,et al.  Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.

[42]  S. Ziegler FOXP3: of mice and men. , 2006, Annual review of immunology.

[43]  A. Rudensky,et al.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.

[44]  S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[45]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[46]  T. Hunter,et al.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Tjian,et al.  Adf-1 Is a Nonmodular Transcription Factor That Contains a TAF-Binding Myb-Like Motif , 1998, Molecular and Cellular Biology.

[48]  R. Costa,et al.  The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix , 1994, Molecular and cellular biology.

[49]  P. S. Kim,et al.  Modular structure of transcription factors: Implications for gene regulation , 1991, Cell.

[50]  B. Powell,et al.  An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. , 1982, The Journal of pediatrics.

[51]  C. Benoist,et al.  Tissue Tregs. , 2016, Annual review of immunology.

[52]  Michael Q. Zhang,et al.  Novel Foxo 1 – dependent transcriptional programs control T reg cell function , 2013 .

[53]  J. Collins,et al.  A multiply redundant genetic switch ‘ locks in ’ the transcriptional signature of regulatory T cells , 2012 .

[54]  A. Freitas,et al.  IPEX and FOXP3: clinical and research perspectives. , 2005, Journal of autoimmunity.